NewslettersMuscle Cell NewsSGLT2 Inhibitor Empagliflozin Promotes Revascularization in Diabetic Mouse Hindlimb Ischemia by Inhibiting FerroptosisBy Jamie Kang - December 12, 20220272Scientists investigated the effects of gliflozins on skeletal muscle cell viability and paracrine function, which were crucial for promoting revascularization in diabetic hindlimb ischemia.[Acta Pharmacologica Sinica]Abstract